{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T16:58:25Z","timestamp":1778691505541,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":1986,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.bbmt.2009.07.014","type":"journal-article","created":{"date-parts":[[2009,9,2]],"date-time":"2009-09-02T04:45:34Z","timestamp":1251866734000},"page":"1447-1454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Busulfan and Cyclophosphamide (Bu\/Cy) as a Preparative Regimen for Autologous Stem Cell Transplantation in Patients with Non-Hodgkin Lymphoma: A Single-Institution Experience"],"prefix":"10.1016","volume":"15","author":[{"given":"Matthew","family":"Ulrickson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Aldridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haesook T.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ephraim P.","family":"Hochberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Hammerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Dube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyal","family":"Attar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen K.","family":"Ballen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bimalangshu R.","family":"Dey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven L.","family":"McAfee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2009.07.014_bib1","first-page":"8","article-title":"Cancer statistics, 2004","volume":"54","author":"Jemal","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bbmt.2009.07.014_bib2","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","article-title":"Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma","volume":"333","author":"Philip","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2009.07.014_bib3","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1200\/JCO.2006.09.8327","article-title":"Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up","volume":"25","author":"Rohatiner","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2009.07.014_bib4","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1200\/JCO.2003.10.023","article-title":"High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP Trial","volume":"21","author":"Schouten","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2009.07.014_bib5","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa031770","article-title":"Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support","volume":"350","author":"Milpied","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2009.07.014_bib6","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/sj.bmt.1705795","article-title":"Prognostic significance of early lymphocyte recovery after post-autografting administration of GM-CSF in non-Hodgkin's lymphoma","volume":"40","author":"Tiwari","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.07.014_bib7","first-page":"595","article-title":"Carmustine, Ara C, cyclophosphamide and etoposide with autologous bone marrow transplantation in relapsed or refractory lymphoma: a dose-finding study","volume":"14","author":"Snyder","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.07.014_bib8","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/sj.bmt.1705841","article-title":"Multicenter study of intravenous busulfan, cyclophosphamide, and etoposide (i.v. Bu\/Cy\/E) as conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin's lymphoma","volume":"40","author":"Kim","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.07.014_bib9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2009.07.014_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.bmt.1705688","article-title":"Comparison of outcomes after transplantation of peripheral blood stem cells versus bone marrow following an identical nonmyeloablative conditioning regimen","volume":"40","author":"Dey","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.07.014_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbmt.2007.03.014","article-title":"Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020","volume":"14","author":"Spitzer","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.07.014_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/bmt.2008.298","article-title":"Autologous SCT with a dose-reduced BU and CY regimen in older patients with non-Hodgkin's lymphoma","volume":"43","author":"Yusuf","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.07.014_bib13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/sj.bmt.1705744","article-title":"Autotransplant conditioning regimens for aggressive lymphoma: are we on the right road?","volume":"40","author":"Fernandez","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.07.014_bib14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s00277-001-0413-8","article-title":"Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma","volume":"81","author":"Hanel","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2009.07.014_bib15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/sj.bmt.1702132","article-title":"Intensified preparative regimens and autologous transplantation in refractory or relapsed intermediate-grade non-Hodgkin's lymphoma","volume":"25","author":"Stein","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.07.014_bib16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1200\/JCO.1998.16.1.48","article-title":"Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens. A Southwest Oncology Group trial","volume":"16","author":"Stiff","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2009.07.014_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bbmt.2004.09.003","article-title":"High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed\/refractory lymphoma: an effective regimen with low morbidity and mortality","volume":"11","author":"Wadhwa","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.07.014_bib18","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.bbmt.2006.03.016","article-title":"Improved outcomes in intermediate- and high-risk aggressive non-Hodgkin lymphoma after autologous hematopoietic stem cell transplantation substituting intravenous for oral busulfan in a busulfan, cyclophosphamide, and etoposide preparative regimen","volume":"12","author":"Aggarwal","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.07.014_bib19","first-page":"9","article-title":"Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicities and hematopoietic recovery","volume":"18","author":"Ballester","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.07.014_bib20","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/sj.bmt.1702433","article-title":"Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma","volume":"25","author":"Copelan","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.07.014_bib21","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/sj.bmt.1700733","article-title":"Busulfan and cyclophosphamide (BU\/CY2) as preparative regimen for patients with lymphoma","volume":"19","author":"de Magalhaes-Silverman","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.07.014_bib22","first-page":"943","article-title":"Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease","volume":"17","author":"Schiffman","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.07.014_bib23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/sj.bmt.1701101","article-title":"High-dose chemotherapy with BUCY or BEAC and unpurged peripheral blood stem cell infusion in patients with low-grade non-Hodgkin's lymphoma","volume":"21","author":"Weaver","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.07.014_bib24","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1080\/10428190802340184","article-title":"High-dose chemotherapy with BEAM or busulphan\/melphalan and thiotepa followed by hematopoietic cell transplantation in malignant lymphoma","volume":"49","author":"Zaucha","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2009.07.014_bib25","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1182\/blood-2008-12-195388","article-title":"Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation","volume":"113","author":"Diez-Martin","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.07.014_bib26","series-title":"The use of intravenous busulfan and cyclophosphamide as a conditioning regimen for non-Hodgkin's lymphoma. Presented at the ASBMT\/CIBMTR Tandem Meetings","author":"Fernandez","year":"2006"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879109003437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879109003437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:35:04Z","timestamp":1761057304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879109003437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S1083879109003437"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2009.07.014","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Busulfan and Cyclophosphamide (Bu\/Cy) as a Preparative Regimen for Autologous Stem Cell Transplantation in Patients with Non-Hodgkin Lymphoma: A Single-Institution Experience","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2009.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}